| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hepatitis B, Chronic | 6 | 2019 | 616 | 0.97 | Why? |
| Nod1 Signaling Adaptor Protein | 2 | 2018 | 23 | 0.94 | Why? |
| Hepatitis B virus | 11 | 2019 | 882 | 0.90 | Why? |
| Pancreatitis, Chronic | 1 | 2017 | 37 | 0.67 | Why? |
| Hepatitis B Virus, Woodchuck | 5 | 2018 | 15 | 0.59 | Why? |
| Nucleotides | 1 | 2017 | 212 | 0.58 | Why? |
| Hepatitis B | 7 | 2018 | 888 | 0.58 | Why? |
| Nucleosides | 1 | 2017 | 221 | 0.56 | Why? |
| Liver | 9 | 2020 | 4007 | 0.54 | Why? |
| Counseling | 1 | 2019 | 747 | 0.48 | Why? |
| Bunyaviridae Infections | 3 | 2018 | 107 | 0.47 | Why? |
| Immunity, Cellular | 4 | 2021 | 3614 | 0.47 | Why? |
| Cell Differentiation | 1 | 2018 | 1338 | 0.46 | Why? |
| Marmota | 4 | 2018 | 19 | 0.46 | Why? |
| Endothelial Cells | 2 | 2018 | 2048 | 0.42 | Why? |
| Nurse's Role | 1 | 2019 | 614 | 0.42 | Why? |
| Phlebovirus | 3 | 2018 | 106 | 0.37 | Why? |
| Hepatitis B e Antigens | 2 | 2019 | 99 | 0.36 | Why? |
| T-Lymphocytes | 5 | 2018 | 6670 | 0.34 | Why? |
| Liver Diseases | 2 | 2020 | 2698 | 0.34 | Why? |
| Hepatitis B Surface Antigens | 3 | 2017 | 305 | 0.33 | Why? |
| CD8-Positive T-Lymphocytes | 6 | 2021 | 5837 | 0.31 | Why? |
| Candida albicans | 2 | 2018 | 217 | 0.31 | Why? |
| Interferon-alpha | 3 | 2019 | 1442 | 0.29 | Why? |
| Acute Disease | 2 | 2019 | 6029 | 0.29 | Why? |
| Dementia | 1 | 2019 | 1861 | 0.28 | Why? |
| Caregivers | 1 | 2019 | 3112 | 0.26 | Why? |
| Chemical and Drug Induced Liver Injury | 2 | 2019 | 451 | 0.25 | Why? |
| Diaminopimelic Acid | 2 | 2018 | 7 | 0.24 | Why? |
| Convalescence | 3 | 2021 | 2829 | 0.22 | Why? |
| Semaphorins | 1 | 2019 | 12 | 0.20 | Why? |
| Tin Compounds | 1 | 2019 | 4 | 0.20 | Why? |
| Hemorrhoids | 1 | 2018 | 17 | 0.19 | Why? |
| Matrix Metalloproteinase 2 | 1 | 2019 | 85 | 0.19 | Why? |
| Natural Killer T-Cells | 1 | 2021 | 191 | 0.19 | Why? |
| Cytochromes b | 1 | 2018 | 23 | 0.19 | Why? |
| Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2018 | 19 | 0.19 | Why? |
| Acetylmuramyl-Alanyl-Isoglutamine | 1 | 2018 | 11 | 0.19 | Why? |
| Hepatitis B Antigens | 1 | 2018 | 19 | 0.19 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 2 | 2020 | 8843 | 0.19 | Why? |
| Disease Models, Animal | 8 | 2018 | 10998 | 0.18 | Why? |
| rho GTP-Binding Proteins | 1 | 2018 | 18 | 0.18 | Why? |
| Kupffer Cells | 1 | 2018 | 34 | 0.18 | Why? |
| Lasers | 1 | 2019 | 132 | 0.18 | Why? |
| Mesothelioma | 1 | 2019 | 76 | 0.18 | Why? |
| GTPase-Activating Proteins | 1 | 2018 | 36 | 0.18 | Why? |
| Matrix Metalloproteinase 9 | 1 | 2019 | 211 | 0.18 | Why? |
| Sulfides | 1 | 2019 | 113 | 0.18 | Why? |
| Peritoneal Neoplasms | 1 | 2019 | 110 | 0.18 | Why? |
| Mitogen-Activated Protein Kinases | 1 | 2018 | 126 | 0.18 | Why? |
| Calcium Phosphates | 1 | 2017 | 35 | 0.18 | Why? |
| Oxides | 1 | 2018 | 77 | 0.17 | Why? |
| Antigen Presentation | 2 | 2018 | 524 | 0.17 | Why? |
| Sustained Virologic Response | 1 | 2019 | 378 | 0.17 | Why? |
| Antigens, CD | 2 | 2020 | 984 | 0.17 | Why? |
| Pancreatitis, Acute Necrotizing | 1 | 2017 | 47 | 0.17 | Why? |
| Quantum Dots | 1 | 2018 | 129 | 0.17 | Why? |
| Poly I-C | 1 | 2017 | 176 | 0.16 | Why? |
| SARS Virus | 2 | 2020 | 13021 | 0.16 | Why? |
| Hepatitis B Core Antigens | 1 | 2017 | 76 | 0.16 | Why? |
| Toll-Like Receptor 2 | 1 | 2018 | 198 | 0.16 | Why? |
| HLA-DRB1 Chains | 1 | 2018 | 196 | 0.16 | Why? |
| Mice, Inbred C57BL | 5 | 2018 | 5542 | 0.16 | Why? |
| Ligands | 2 | 2018 | 1300 | 0.16 | Why? |
| Intraabdominal Infections | 1 | 2017 | 90 | 0.16 | Why? |
| Interleukin-2 | 1 | 2018 | 443 | 0.16 | Why? |
| Hepatitis A Virus Cellular Receptor 2 | 1 | 2017 | 98 | 0.16 | Why? |
| T-Lymphocytes, Cytotoxic | 1 | 2020 | 552 | 0.16 | Why? |
| Photochemotherapy | 2 | 2018 | 297 | 0.16 | Why? |
| Galectins | 1 | 2017 | 109 | 0.15 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.15 | Why? |
| Cholestasis | 1 | 2017 | 114 | 0.15 | Why? |
| Fatty Acids | 1 | 2017 | 238 | 0.15 | Why? |
| Behavior Therapy | 1 | 2018 | 235 | 0.15 | Why? |
| Liver Failure, Acute | 1 | 2019 | 279 | 0.15 | Why? |
| Photosensitizing Agents | 1 | 2017 | 279 | 0.14 | Why? |
| DNA, Viral | 4 | 2018 | 2521 | 0.14 | Why? |
| Toll-Like Receptor 3 | 1 | 2017 | 391 | 0.14 | Why? |
| Th2 Cells | 1 | 2018 | 680 | 0.14 | Why? |
| Graphite | 1 | 2018 | 318 | 0.14 | Why? |
| Polyethylene Glycols | 1 | 2019 | 574 | 0.14 | Why? |
| Communicable Diseases, Emerging | 2 | 2020 | 2523 | 0.14 | Why? |
| Plasmids | 1 | 2017 | 840 | 0.14 | Why? |
| End Stage Liver Disease | 1 | 2019 | 418 | 0.13 | Why? |
| Lymphocyte Activation | 3 | 2019 | 2742 | 0.13 | Why? |
| Nomograms | 1 | 2020 | 790 | 0.13 | Why? |
| Candidiasis | 1 | 2018 | 334 | 0.13 | Why? |
| Betacoronavirus | 11 | 2020 | 204454 | 0.12 | Why? |
| Th17 Cells | 1 | 2018 | 657 | 0.12 | Why? |
| Polymers | 1 | 2017 | 507 | 0.12 | Why? |
| Immune Tolerance | 1 | 2018 | 608 | 0.12 | Why? |
| Lymphocyte Subsets | 1 | 2020 | 987 | 0.12 | Why? |
| Mice | 12 | 2019 | 21357 | 0.12 | Why? |
| Triazoles | 1 | 2017 | 440 | 0.12 | Why? |
| Nucleic Acids | 1 | 2017 | 435 | 0.12 | Why? |
| Reactive Oxygen Species | 1 | 2018 | 1136 | 0.12 | Why? |
| Th1 Cells | 1 | 2018 | 1228 | 0.12 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2018 | 698 | 0.12 | Why? |
| Animals | 18 | 2020 | 78931 | 0.11 | Why? |
| Metal Nanoparticles | 1 | 2019 | 771 | 0.11 | Why? |
| Orthomyxoviridae | 1 | 2020 | 1168 | 0.11 | Why? |
| Minimally Invasive Surgical Procedures | 1 | 2017 | 663 | 0.11 | Why? |
| Alanine Transaminase | 1 | 2017 | 1329 | 0.11 | Why? |
| Interleukin-10 | 1 | 2018 | 1409 | 0.11 | Why? |
| NF-kappa B | 1 | 2018 | 1301 | 0.11 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 907 | 0.11 | Why? |
| Ultraviolet Rays | 1 | 2020 | 1272 | 0.11 | Why? |
| Virus Inactivation | 1 | 2020 | 1139 | 0.11 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.11 | Why? |
| L-Lactate Dehydrogenase | 1 | 2019 | 1995 | 0.10 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.10 | Why? |
| Phenotype | 2 | 2021 | 4037 | 0.10 | Why? |
| Up-Regulation | 1 | 2018 | 2249 | 0.10 | Why? |
| Leukocyte Count | 1 | 2020 | 3178 | 0.10 | Why? |
| Mice, Transgenic | 4 | 2018 | 2739 | 0.10 | Why? |
| China | 10 | 2020 | 50654 | 0.10 | Why? |
| Immunoglobulin M | 3 | 2021 | 9091 | 0.10 | Why? |
| Singlet Oxygen | 2 | 2018 | 17 | 0.09 | Why? |
| Survival Rate | 2 | 2020 | 9206 | 0.09 | Why? |
| Pancreatitis | 1 | 2017 | 688 | 0.09 | Why? |
| Humans | 42 | 2021 | 930598 | 0.09 | Why? |
| ROC Curve | 2 | 2019 | 6024 | 0.09 | Why? |
| Hepatitis, Viral, Animal | 2 | 2017 | 274 | 0.09 | Why? |
| Nutritional Status | 1 | 2019 | 1403 | 0.09 | Why? |
| Immunization | 1 | 2017 | 2019 | 0.09 | Why? |
| Virus Replication | 4 | 2018 | 14331 | 0.09 | Why? |
| Drug Delivery Systems | 1 | 2017 | 1365 | 0.09 | Why? |
| Seroconversion | 1 | 2017 | 2515 | 0.08 | Why? |
| Female | 25 | 2021 | 380317 | 0.08 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.08 | Why? |
| Male | 23 | 2021 | 367725 | 0.08 | Why? |
| Antifungal Agents | 1 | 2017 | 1828 | 0.08 | Why? |
| Gene Expression | 1 | 2017 | 3332 | 0.08 | Why? |
| Endoscopy | 1 | 2017 | 1564 | 0.08 | Why? |
| Glucocorticoids | 1 | 2021 | 4431 | 0.07 | Why? |
| Adult | 16 | 2021 | 244371 | 0.07 | Why? |
| Time-to-Treatment | 2 | 2021 | 5883 | 0.07 | Why? |
| Nanoparticles | 1 | 2017 | 2040 | 0.07 | Why? |
| Antibodies, Neutralizing | 3 | 2021 | 25288 | 0.07 | Why? |
| HeLa Cells | 2 | 2019 | 1303 | 0.07 | Why? |
| Cause of Death | 1 | 2019 | 4823 | 0.07 | Why? |
| Drug Design | 1 | 2017 | 2627 | 0.07 | Why? |
| Antiviral Agents | 4 | 2019 | 41703 | 0.07 | Why? |
| Dietary Supplements | 1 | 2017 | 2251 | 0.07 | Why? |
| Thrombocytopenia | 1 | 2018 | 2093 | 0.07 | Why? |
| Social Support | 1 | 2019 | 3183 | 0.07 | Why? |
| Adaptation, Psychological | 2 | 2020 | 4996 | 0.07 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.06 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.06 | Why? |
| Middle Aged | 16 | 2021 | 270681 | 0.06 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.06 | Why? |
| T-Lymphocyte Subsets | 2 | 2021 | 1387 | 0.06 | Why? |
| Mental Health | 2 | 2020 | 15770 | 0.06 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.06 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.06 | Why? |
| Liver Function Tests | 2 | 2019 | 1325 | 0.06 | Why? |
| Aged | 12 | 2021 | 215776 | 0.06 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.05 | Why? |
| Cytotoxins | 1 | 2020 | 57 | 0.05 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.05 | Why? |
| Fever | 1 | 2018 | 7795 | 0.05 | Why? |
| Arousal | 1 | 2020 | 53 | 0.05 | Why? |
| Pandemics | 10 | 2020 | 389249 | 0.05 | Why? |
| Immunologic Factors | 1 | 2017 | 4206 | 0.05 | Why? |
| Flow Cytometry | 2 | 2020 | 2393 | 0.05 | Why? |
| Dose-Response Relationship, Drug | 2 | 2021 | 3776 | 0.05 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
| Cytotoxicity, Immunologic | 1 | 2021 | 287 | 0.05 | Why? |
| Genetic Background | 1 | 2018 | 11 | 0.05 | Why? |
| Th1-Th2 Balance | 1 | 2018 | 19 | 0.05 | Why? |
| Genome, Viral | 2 | 2020 | 13157 | 0.05 | Why? |
| Asbestos | 1 | 2019 | 45 | 0.05 | Why? |
| Superoxides | 1 | 2018 | 36 | 0.05 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.05 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.05 | Why? |
| Inflammation | 1 | 2021 | 13255 | 0.05 | Why? |
| Transplantation, Heterologous | 1 | 2019 | 77 | 0.05 | Why? |
| Diploidy | 1 | 2018 | 6 | 0.05 | Why? |
| Haploidy | 1 | 2018 | 6 | 0.05 | Why? |
| Lymphocyte Count | 2 | 2021 | 4758 | 0.05 | Why? |
| Tupaia | 1 | 2018 | 8 | 0.05 | Why? |
| Gene Expression Regulation, Fungal | 1 | 2018 | 21 | 0.05 | Why? |
| Registries | 1 | 2019 | 12327 | 0.05 | Why? |
| Chimera | 1 | 2018 | 83 | 0.04 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.04 | Why? |
| Mice, Nude | 1 | 2019 | 340 | 0.04 | Why? |
| Hepadnaviridae Infections | 1 | 2017 | 4 | 0.04 | Why? |
| Ducks | 1 | 2018 | 120 | 0.04 | Why? |
| Pan troglodytes | 1 | 2018 | 157 | 0.04 | Why? |
| Click Chemistry | 1 | 2017 | 66 | 0.04 | Why? |
| Porphyrins | 1 | 2017 | 88 | 0.04 | Why? |
| Phototherapy | 1 | 2019 | 138 | 0.04 | Why? |
| Surveys and Questionnaires | 3 | 2020 | 43792 | 0.04 | Why? |
| CD4 Antigens | 1 | 2018 | 306 | 0.04 | Why? |
| Time Factors | 4 | 2021 | 31397 | 0.04 | Why? |
| Adoptive Transfer | 1 | 2018 | 250 | 0.04 | Why? |
| Surface Properties | 1 | 2018 | 448 | 0.04 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.04 | Why? |
| Severity of Illness Index | 6 | 2021 | 48226 | 0.04 | Why? |
| Lymphocyte Depletion | 1 | 2018 | 293 | 0.04 | Why? |
| THP-1 Cells | 1 | 2017 | 374 | 0.04 | Why? |
| Mice, Inbred BALB C | 2 | 2017 | 5814 | 0.04 | Why? |
| Confidence Intervals | 1 | 2019 | 744 | 0.04 | Why? |
| Cell Separation | 1 | 2018 | 270 | 0.04 | Why? |
| Antigens, Viral | 3 | 2018 | 6298 | 0.04 | Why? |
| Light | 1 | 2018 | 306 | 0.04 | Why? |
| Rodentia | 1 | 2017 | 235 | 0.04 | Why? |
| Capillaries | 1 | 2018 | 257 | 0.04 | Why? |
| Amino Acid Sequence | 2 | 2018 | 6049 | 0.04 | Why? |
| Prognosis | 4 | 2020 | 32490 | 0.04 | Why? |
| Lipopeptides | 1 | 2018 | 229 | 0.04 | Why? |
| Toll-Like Receptors | 1 | 2018 | 365 | 0.04 | Why? |
| Linear Models | 1 | 2021 | 1914 | 0.04 | Why? |
| Genetic Association Studies | 1 | 2018 | 559 | 0.04 | Why? |
| Viral Proteins | 1 | 2013 | 7370 | 0.04 | Why? |
| DNA, Complementary | 1 | 2017 | 568 | 0.04 | Why? |
| Depression | 1 | 2019 | 14116 | 0.03 | Why? |
| Necrosis | 1 | 2017 | 532 | 0.03 | Why? |
| Drug Synergism | 1 | 2017 | 833 | 0.03 | Why? |
| Spleen | 1 | 2018 | 877 | 0.03 | Why? |
| Drainage | 1 | 2017 | 414 | 0.03 | Why? |
| Cloning, Molecular | 1 | 2017 | 1036 | 0.03 | Why? |
| Particle Size | 1 | 2018 | 1052 | 0.03 | Why? |
| Murine hepatitis virus | 1 | 2002 | 1720 | 0.03 | Why? |
| Hydrogen Peroxide | 1 | 2018 | 680 | 0.03 | Why? |
| History, 21st Century | 1 | 2020 | 1849 | 0.03 | Why? |
| Hepatitis B Antibodies | 1 | 2013 | 142 | 0.03 | Why? |
| Cell Survival | 1 | 2018 | 1581 | 0.03 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.03 | Why? |
| HIV Infections | 1 | 2018 | 11620 | 0.03 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.03 | Why? |
| Molecular Structure | 1 | 2017 | 1539 | 0.03 | Why? |
| Syndrome | 1 | 2016 | 1310 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.03 | Why? |
| Sex Distribution | 1 | 2019 | 2083 | 0.03 | Why? |
| Leukocytes, Mononuclear | 1 | 2021 | 2115 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Methylprednisolone | 1 | 2021 | 2107 | 0.03 | Why? |
| Apoptosis | 1 | 2021 | 2335 | 0.03 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2017 | 2219 | 0.03 | Why? |
| Uterine Cervical Neoplasms | 1 | 2019 | 842 | 0.03 | Why? |
| Cell Proliferation | 1 | 2018 | 1973 | 0.03 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.03 | Why? |
| Recombination, Genetic | 1 | 2017 | 1265 | 0.02 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.02 | Why? |
| Biomarkers, Tumor | 1 | 2019 | 1314 | 0.02 | Why? |
| Age Distribution | 1 | 2019 | 3567 | 0.02 | Why? |
| Temperature | 1 | 2019 | 2305 | 0.02 | Why? |
| Recombinant Proteins | 1 | 2019 | 3786 | 0.02 | Why? |
| Base Sequence | 1 | 2017 | 3581 | 0.02 | Why? |
| Heparin | 1 | 2021 | 2600 | 0.02 | Why? |
| Blood Coagulation | 1 | 2021 | 2768 | 0.02 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1573 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2017 | 2886 | 0.02 | Why? |
| Lymphopenia | 1 | 2020 | 2669 | 0.02 | Why? |
| Interferon-gamma | 1 | 2018 | 2711 | 0.02 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2019 | 3788 | 0.02 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.02 | Why? |
| Killer Cells, Natural | 1 | 2017 | 2093 | 0.02 | Why? |
| Disinfection | 1 | 2020 | 2912 | 0.02 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.02 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Incidence | 2 | 2019 | 25622 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 5993 | 0.02 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.02 | Why? |
| Anti-HIV Agents | 1 | 2018 | 2209 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2020 | 4418 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2020 | 4545 | 0.02 | Why? |
| Anti-Infective Agents | 1 | 2017 | 1766 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2018 | 3607 | 0.02 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.02 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.02 | Why? |
| Models, Biological | 1 | 2021 | 4907 | 0.02 | Why? |
| Biomarkers | 2 | 2017 | 23361 | 0.02 | Why? |
| Chronic Disease | 1 | 2019 | 5139 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2017 | 2844 | 0.02 | Why? |
| Drug Discovery | 1 | 2018 | 3092 | 0.02 | Why? |
| Transcriptome | 1 | 2017 | 3466 | 0.02 | Why? |
| Neutrophils | 1 | 2020 | 5476 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2020 | 53120 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.01 | Why? |
| Logistic Models | 1 | 2016 | 9089 | 0.01 | Why? |
| Drugs, Chinese Herbal | 1 | 2017 | 2760 | 0.01 | Why? |
| Protein Binding | 1 | 2018 | 11430 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2019 | 17020 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2016 | 11304 | 0.01 | Why? |
| Models, Statistical | 1 | 2016 | 5312 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 11367 | 0.01 | Why? |
| Phylogeny | 1 | 2017 | 13341 | 0.01 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.01 | Why? |
| Viral Load | 1 | 2017 | 15850 | 0.01 | Why? |
| Sex Factors | 1 | 2013 | 11014 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.01 | Why? |
| RNA, Viral | 1 | 2018 | 32276 | 0.01 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.01 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |